FEASIBILITY STUDY OF INTRAOCULAR ROBOTIC SURGERY WITH THE da VINCI SURGICAL SYSTEM

OBJECTIVEThe aim of this study was to confirm the feasibility of an innovative transoral robotic surgery (TORS), using the da Vinci Surgical System, for patients with sellar tumors. This technique was designed to offer a new minimally invasive approach, without soft-palate splitting, that avoids the rhinological side effects of classic endonasal approaches.METHODSThe authors performed a prospective study of TORS in patients with symptomatic sellar tumors. Specific anatomical features were required for inclusion in the study and were determined on the basis of preoperative open-mouth CT scans of the brain. The main outcome measure was sellar accessibility using the robot. Resection quality, mean operative time, postoperative changes in patients' vision, side effects, and complications were additionally reported.RESULTSBetween February and May 2016, 4 patients (all female, mean age 49.5 years) underwent TORS for resection of sellar tumors as participants in this study. All patients presented with symptomatic visual deficits confirmed as bitemporal hemianopsia. All tumors had a suprasellar portion and a cystic part. In all 4 cases, the operation was performed via TORS, without the need for a second surgery. Sella turcica accessibility was satisfactory in all cases. In 3 cases, tumor resection was complete. The mean operative time was 2 hours 43 minutes. Three patients had a significant visual improvement at Day 1. No rhinological side effects or complications in patients occurred. No pathological examination was performed regarding the fluid component of the tumors. There was 1 postoperative delayed CSF leak and 1 case of transient diabetes insipidus. Side effects specific to TORS included minor sore throat, transient hypernasal speech, and 1 case of delayed otitis media. The mean length of hospital stay and mean follow up were 8.25 days and 82 days, respectively.CONCLUSIONSTo our knowledge, this is the first report of the surgical treatment of sellar tumors by means of a minimally invasive TORS. This approach using the da Vinci Surgical System seems feasible and constitutes an innovative neurosurgical technique that may avoid the adverse side effects and technical disadvantages of the classic transsphenoidal route. Moreover, TORS allows an inferosuperior approach to the sella turcica, which is a key point, as the tumor is approached in the direction of its growth.

Download Full-text

Trends in the adoption of robotic technology in the surgical management of prostate cancer: A population-based analysis.

Journal of Clinical Oncology ◽

10.1200/jco.2012.30.5_suppl.258 ◽

2012 ◽

Vol 30 (5_suppl) ◽

pp. 258-258

Author(s):

Steven Lee Chang ◽

Wei Jiang ◽

Benjamin I. Chung

Keyword(s):

Prostate Cancer ◽

Robotic Surgery ◽

Radical Prostatectomy ◽

Surgical Management ◽

Da Vinci ◽

Population Based ◽

Da Vinci Surgical System ◽

Robotic Technology ◽

Vinci Surgical System ◽

Surgical System

258 Background: The adoption of the da Vinci Surgical System (Intuitive Surgical, Inc) for robotic surgery requires a substantial financial investment by hospitals, acquisition of new surgical skills by surgeons, and demand from patients. Although the benefits of this technology have been previously described, the prevalence and adoption rate for the treatment of prostate cancer is not currently known. We performed a population-based analysis to determine how the introduction of robotic technology has altered the surgical management of prostate cancer. Methods: We analyzed patient-level data from the Prospective Rx Comparative Database (Premier, Inc., Charlotte, NC), which collects data from over 600 non-federal hospitals throughout the United States. We captured all men who underwent a radical prostatectomy between January 1, 2003, and December 31, 2010, based on the International Classification of Disease, 9th edition. Radical prostatectomies utilizing the da Vinci Surgical System were identified by a detailed review of the hospital charge data. Descriptive analysis with univariate and multivariate statistical analyses were performed. Results: Prior to 2006, <10% of radical prostatectomies were performed with robotic surgery. Beginning in 2006 there was a rapid rise in adoption reaching 56% utilization in 2009 and leveling off in 2010 to 54%. Adjusted analysis demonstrated that the odds of adopting robotic surgery were higher in teaching hospital (odds ratio [OR] 1.45, p<0.001) and hospitals in the Northeast (vs Midwest [OR 2.99, p<0.001]). Smaller hospitals (<200 beds) had a lower likelihood of adopting robotic surgery (OR 0.4, p<0.001). Patient age had no impact on the odds of undergoing robotic radical prostatectomy. Conclusions: Over past 5 years, there has been widespread adoption of robotic surgery in the management of prostate cancer now with just over half of procedures performed with the da Vinci Surgical System. Our analysis suggests that the adoption of robotic surgery has been determined primarily by the acquisition of this technology by hospitals, which was more common in teaching institutions, larger hospitals, and hospitals in the Northeast.

Download Full-text

Faculty Opinions recommendation of Does training on a virtual reality robotic simulator improve performance on the da Vinci surgical system?

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3637957.3355055 ◽

2010 ◽

Author(s):

Thomas Polascik ◽

Matvey Tsivian

Keyword(s):

Virtual Reality ◽

Da Vinci ◽

Da Vinci Surgical System ◽

Improve Performance ◽

Robotic Simulator ◽

Vinci Surgical System ◽

Surgical System

Download Full-text

Automated Support for da Vinci Surgical System

10.21236/ada546095 ◽

2011 ◽

Cited By ~ 1

Author(s):

Jeffrey Berkley

Keyword(s):

Da Vinci ◽

Da Vinci Surgical System ◽

Automated Support ◽

Vinci Surgical System ◽

Surgical System

Download Full-text

A Scoping Review of Emerging and Established Surgical Robotic Platforms With Applications in Urologic Surgery

Société Internationale d’Urologie Journal ◽

10.48083/ewwq2677 ◽

2021 ◽

pp. 300-310

Author(s):

Braden Millan ◽

Shavy Nagpal ◽

Maylynn Ding ◽

Jason Y. Lee ◽

Anil Kapoor

Keyword(s):

Da Vinci ◽

Da Vinci Surgical System ◽

Pubmed Central ◽

Urologic Surgery ◽

Additional Information ◽

Surgery Research ◽

Robotic Platforms ◽

Distinct Features ◽

Vinci Surgical System ◽

Surgical System

Objectives Since the introduction of the first master–slave robotic platform for surgical procedures, there have been ongoing modifications and development of new platforms, but there is still a paucity of commercially available systems. Our study aims to identify all master–slave robotic surgical platforms currently commercially available or in development around the world with applications in urologic surgery. Methods A scoping literature search was performed using PRISMA methodology to identify all relevant publications in English in PubMed, PubMed Central, and Embase, with additional information being obtained from official company websites. Results Ten robotic platforms with either proven or potential application in urologic surgery were identified: the da Vinci surgical system (Intuitive), Senhance surgical system (Transentrix), Versius Surgical (CMR Ltd), Enos surgical system (Titan Medical), Revo –I (Meere Company), MiroSurge (DLR), Avatera System (Avatera Medical), Hugo Surgical Robot (Medtronic), Ottava (J&J, Ethicon, Areus), and Hinotori (Medicaroid Corporation). Conclusions This review highlights the distinct features of emerging master–slave robotic platforms with applications in urologic surgery. Research and development are now focused on finding wider applications, improving outcomes, increasing availability, and reducing cost. Additional research is required comparing newly developed master–slave robotic platforms with those already well established.

Download Full-text